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 Abstract 
 Objective. Laboratory tests are ordered on a daily basis, even though disease probability is often very low. Abnormal 
results, especially mildly abnormal results, can be diffi cult to interpret in these circumstances. Further insights into the 
occurrence of abnormalities can help improve rational test ordering and test interpretation. The objective was therefore to 
examine the frequency of mildly and markedly abnormal results and their relationship with physicians’ reasons for order ing 
tests.  Design. Prospective study.  Participants . A total of 87 primary care physicians in the Netherlands collected data 
on 1775 patients.  Main outcome measures.  The physicians recorded the reason for ordering the tests, the most probable 
diagnosis and the pretest probability. The laboratories’ reference values and specifi ed “action limits” were used to assess 
the number of abnormal results and markedly abnormal results, respectively.  Results . Laboratory results were received 
for 1621 patients and 15,603 tests were reported (mean 9.6). The proportion of abnormal test results increased with 
increasing pretest probability (from 13.9% to 34.7%) and was 13.4% for tests ordered to reassure the patient and 13.3% 
for psychosocial diagnoses. The proportion of patients with at least one abnormal test result was high: 53.1% for tests 
ordered to reassure and 57.7% in patients with low pretest probability. Corresponding values for a marked abnormality 
were 11.1% and 12.4%, respectively.  Conclusion. Abnormal laboratory test results were frequent, even when pretest 
probability was low. Physicians should therefore carefully consider when tests are necessary. Future research could explore 
physicians’ interpretation of test results and its impact on diagnosis and management. 
Key  Words:  Clinical chemistry tests ,  diagnostic tests ,  family practice ,  interpretation of laboratory tests ,  laboratory utilization ,  primary 
 healthcare 
 In primary care, correct interpretation of abnormal 
test results may be diffi cult. For instance, abnor-
mal results can sometimes lead to an unjustifi ed 
cascade of further investigations [ 1 , 2] , while on the 
other hand they may erroneously fail to be further 
investigated [ 3 ]. 
 These diffi culties with the interpretation of 
abnormal results may have several causes. For 
example, the pretest probability of disease is usually 
low in primary care. Also, physicians may suspect 
that complaints and symptoms are related to 
psychosocial problems [ 4 , 5 ]. Many tests are indeed 
ordered for reasons such as excluding pathology or 
reassuring the patient [ 6 – 8 ]. Furthermore, many 
abnormal lab results represent only minor devia-
tions, and physicians may doubt their clinical 
relevance [ 9] . It is in particular the combination of 
minor abnormalities and a low pretest probab-
ility which may be diffi cult to interpret, as it is often 
easier to decide on the basis of more markedly 
abnormal results. 
 While several authors reported high percentages 
of abnormal laboratory results [ 10 , 11 ], the relation-
ship with the physicians’ reasons for ordering tests 
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 Reasons for ordering lab tests and frequency of abnormal results 19
for Health Services Research (NIVEL). To prevent 
selection bias, each participating physician was 
personally instructed to include and to record data 
on the fi rst 25 consecutive adult patients for whom 
they had decided to order laboratory tests. Also, to 
prevent physicians from changing their ordering 
patterns, it was stressed that we did not intend to 
measure performance or to give feedback on test 
ordering. Physicians working part time included 
a smaller number of patients, proportional to the 
number of hours a week they were working. Patients 
were asked to give informed consent. 
 Measurements 
 The physicians recorded data when they ordered the 
laboratory tests, using forms that were specifi cally 
designed for the study and took about two minutes 
to complete. The forms had been pilot-tested and 
evaluated as regards validity, reliability, and user con-
venience in an iterative process among a sample of 
10 primary care physicians and a questionnaire 
expert. The laboratories provided the researchers 
with a copy of the laboratory results. 
 Outcome variables 
 Test results . We used the reference values from the 
laboratories, adjusted for age and sex where appro-
priate, to determine the number of abnormal results. 
We asked an expert group to help us discriminate 
between minor and marked abnormalities. This 
expert group comprised two clinical chemists, one 
primary care physician with expertise in laboratory 
testing, and two primary care physicians from 
the research team. The experts went through a con-
sensus procedure to specify action limits for tests, 
and the frequency of mildly or markedly abnormal 
results are unknown. More information on this rela-
tionship could be important for education as well as 
to improve rational test ordering. It may also help in 
exploring areas of potential diffi culty in the interpre-
tation of results. 
 The aim of this study was therefore to examine 
the frequency of mildly and markedly abnormal 
results in routine practice, and to investigate how they 
relate to the reasons for ordering laboratory tests. 
 Material and methods  
 Design and setting 
 We conducted a prospective study among 87 primary 
care physicians and their patients in seven rural, 
suburban, and urban areas in the south of the 
Netherlands. Physicians’ age, sex, and working time 
were representative of those in the Netherlands 
according to data from the Netherlands Institute 
Table I. Reference values, action limits, and abnormal results.
Test N tests
% abnormal test results according 
to reference values (95% CI) Action limits
% markedly abnormal test results 
according to action limits (95% CI)
ALAT (U/l) 440 10% (8%–13%)  70 3% (1%–4%)
Cholesterol (mmol/l) 584 38% (34%–41%)  8.0 3% (1%–4%)
Creatinine clearance 
 (ml/min/1.73 m2)1
780 61% (58%–65%)  60 21% (18%–24%)
CRP (mg/l) 175 38% (31%–45%)  50 5% (1%–8%)
ESR (mm/hr) 877 22% (19%–25%)  40 5% (3%–6%)
Ferritin (µg/l) 57 47% (34%–60%) 15–1000 35% (23%–47%)
Gamma GT (U/l) 239 24% (19%–30%)  90 6% (3%–9%)
Glucose (mmol/l) 949 8% (6%–9%) 3.0–11.0 2% (1%–3%)
Hemoglobin (mmol/l) 878 13% (11%–16%) ♀6.5–10.5, ♂ 7.5–11.5 2% (1%–3%)
Leukocytes (∗10e9/l) 574 13% (10%–25%) 2.5–15.0 2% (1%–3%)
MCV (fl ) 716 6% (5%–8%) 75–105 1% (0%–2%)
Potassium (mmol/l) 334 16% (12%–20%) 3.0–5.5 1% (0%–3%)
Sodium (mmol/l) 137 7% (2%–11%) 130–150 0%
TSH (mU/l) 660 11% (9%–13%) 0.1–8.0 5% (3%–7%)
Note: 1MDRD formula, adjusted to the laboratory method for creatinine measurement (jaffe/enzymatic).
Tests are often ordered even though disease 
probability is low. The frequency of abnormal 
results in these situations was unknown.
Even when tested for reasons such as   •
“patient reassurance”, many patients have 
abnormal results.
Most abnormalities are only slightly   •
abnormal.
Physicians should carefully consider when   •
tests are necessary. Future research could 
explore the interpretation of results and the 
impact on diagnosis and management. 
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 Presumed diagnosis . Physicians recorded their 
most likely diagnosis at the time of test ordering. 
We coded these according to the International Clas-
sifi cation of Primary Care (ICPC), defi ning two 
groups: (1) the most likely diagnosis refers to non-
somatic disease, i.e. ICPC chapters P (psychological) 
and Z (social) and ICPC code A97 (“no disease”); 
and (2) all other diagnoses. 
 Analysis 
 We used SPSS 15 to analyze the data. We counted 
the number of abnormal test results according to the 
reference values and the number of markedly abnor-
mal test results based on the action limits (test level). 
We also counted the number of patients with at least 
one abnormal or one markedly abnormal test result 
(patient level). We used the Chi-square test to test for 
signifi cant differences in the numbers of patients 
with abnormal results within the categories of age, 
sex, reason for ordering tests, presumed diagnosis, 
and estimated pretest probability. 
 Results  
 A total of 87 primary care physicians participated in 
the study, and they included 1775 patients. We 
indicating values for which they considered urgent 
medical intervention to be necessary. The action 
limits were established in an iterative process and 
were based as much as possible on evidence-based 
guidelines and the literature. After three discussion 
rounds, consensus regarding the action limits for 14 
tests was reached (see  Table I ). 
 Independent variables 
 Reason for ordering tests . We distinguished nine rea-
sons for test ordering, which were chosen on the 
basis of a qualitative interview study among primary 
care physicians [ 12 ]. Physicians recorded the most 
important reason for ordering the investigations by 
ticking one of nine boxes. We summarized these into 
fi ve categories: (1) to exclude disease and reduce the 
physician’s uncertainty, (2) to confi rm diagnosis and 
to determine treatment, (3) to reassure patients and 
at patient’s request, (4) monitoring of disease (screen-
ing for hypertension/cholesterol/diabetes and check-up 
for known disorder), and (5) other reasons. 
 Estimated pretest disease probability . The form phy-
sicians had to complete at the time of test ordering 
asked: “Do you suspect a disease?” The physicians 
answered on a fi ve-point Likert scale: “defi nitely 
not”, “probably not”, “maybe”, “probably yes” and 
“defi nitely yes”. 
Table II. Distribution of abnormal test results at test level.1
N tests
% abnormal test results according 
to reference values
% markedly abnormal tests according 
to action limits
Patients (n  1484) 7400 20.7% 4.9%
Sex
 Men 2857 21.4% 4.3%
 Women 4543 20.3% 5.3%
Age
  40 years 1747 13.7% 2.5%
 40–60 years 2773 19.8% 4.0%
  60 years 2880 25.8% 7.4%
Reason for ordering tests
 Confi rm/determine treatment 725 27.2% 9.1%
 Exclude/physician’s uncertainty 3654 18.6% 4.2%
 Reassure/patient’s request 1139 13.4% 2.0%
 Monitoring (screening/check-up) 1761 27.0% 6.6%
 Other reasons 33 15.2% 3.0%
Estimated pretest probability2
 Defi nitely no disease 541 13.9% 2.2%
 Probably no disease 1990 14.2% 2.6%
 Possibly disease 1651 19.9% 4.5%
 Probably disease 1127 24.3% 7.0%
 Defi nitely disease 196 34.7% 14.3%
Presumed diagnosis2
 A97, P, Z 1083 13.3% 2.7%
 Other ICPC codes 4350 20.1% 4.9%
Notes: 1Limited to the 14 tests in Table I. 2The physicians did not estimate a pretest probability or mention a presumed diagnosis if they 
ordered the tests for screening or check-up.
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 Reasons for ordering lab tests and frequency of abnormal results 21
 At patient level, the frequency of patients with 
one or more abnormal test results was considerable 
( Table III ). Even if the physician had ordered to reas-
sure, 53.1% of the patients had abnormal results and 
11.1% had a markedly abnormal result. Patients’ age 
and sex, the reason for ordering tests, and the esti-
mated pretest probability were signifi cantly related to 
the percentage of patients with abnormal results. 
 Discussion 
 This study shows that many patients have abnormal 
laboratory test results, even when the tests are 
ordered in a situation of low pretest probability, such 
as to reassure patients (53.1%) or to exclude disease 
(62.5%). A large proportion of the abnormal test 
results were only mildly abnormal. Given the low 
pretest probability and the statistical defi nition of 
reference values, there is a fair chance that the 
abnormalities may not have clinical signifi cance in 
terms of diagnosis or therapy [ 13 ]. This underlines 
the necessity for physicians to carefully consider 
their orders for laboratory tests. It also raises the 
question of what exactly physicians do with these 
results. Future research should therefore attempt to 
explore how physicians interpret these test results, 
and what the diagnostic and therapeutic conse-
quences are.  
received no laboratory results for 154 patients (8.7%), 
the most important reasons being failure to visit the 
laboratory (31.8%) and failure to give informed con-
sent (13.6%), while the reason could not be retrieved 
in 42.9% of the cases. The laboratories reported 
15,603 tests for the remaining 1621 patients. The 
mean of reported tests was 9.9 for tests ordered to 
exclude disease, 8.9 for tests ordered to reassure, 
and 7.9 for tests ordered for monitoring. There were 
2875 (18.4%) abnormal test results according to the 
reference values. The 1621 patients included 440 
(27.1%) with one abnormal test result, 310 (19.1%) 
with two abnormal test results, and 437 (27.0%) 
with three or more abnormal test results. 
 The tests for which action limits had been 
specifi ed accounted for 47.4% (n  7400) of all 
reported tests (n  15,603). There were 1484 (1484/ 
1621  91.5%) patients for whom at least one of 
these tests was ordered. ( Table I ) shows how often 
each test was reported and the percentage of abnor-
mal and markedly abnormal test results. 
 At test level, the frequency of markedly abnormal 
test results was clearly smaller than the frequency of 
abnormal test results ( Table II ). The frequency of 
abnormal test results increased with increasing age 
(13.7%–25.8%) and increasing pretest probability 
(13.9%–34.7%), and was high for tests ordered to 
confi rm disease (27.2%) and for screening (27.0%). 
Table III. Distribution of abnormal result at patient level.1
Reasons for ordering tests N patients
% patients with abnormal results 
according to reference values (95% CI)
% patients with markedly abnormal results 
according to action limits (95% CI)
Patients 1484 64% (61%–66%) 21% (19%–23%)
Sex
 Men 591 (40%) 63% (60%–67%) 18% (15%–21%)∗
 Women 893 (60%) 64% (61%–67%) 23% (20%–6%)
Age
  40 years 343 (23%) 48% (42%–53%)∗∗∗ 10% (7%–13%)∗∗∗
 40–60 years 582 (39%) 60% (57%–64%) 16% (13%–20%)
  60 years 559 (38%) 77% (74%–81%) 33% (29%–37%)
Reason for ordering tests 16 missing
 Confi rm/determine treatment 167 (11%) 68% (61%–75%)∗∗∗ 30% (23%–37%)∗∗
 Exclude/physician’s 651 (44%) 63% (59%–66%) 20% (17%–23%)
 Uncertainty 207 (14%) 53% (46%–60%) 11% (7%–15%)
 Reassure/patient’s request 434 (29%) 69% (65%–73%) 24% (20%–27%)
 Monitoring (screening/check-up)  9 (1%) 33% (7%–69%) 11% (0%–48%)
 Other reasons
Estimated pretest probability2 28 missing
 Defi nitely no disease 97 (9%) 58% (48%–68%)∗∗∗ 12% (6%–19%)∗∗∗
 Probably no disease 353 (34%) 54% (48%–59%) 14% (10%–17%)
 Possibly disease 301 (29%) 66% (60%–71%) 22% (17%–27%)
 Probably disease  218(21%) 69% (63%–75%) 28% (22%–33%)
 Defi nitely disease 53 (5%) 70% (57%–82%) 40% (26%–53%)
Presumed diagnosis2 38 missing
 A97, P, Z 173 (17%) 58% (51%–66%) 16% (10%–21%)
 Other ICPC codes 839 (83%) 62% (59%–65%) 21% (18%–24%)
Notes: ∗ p  0.05 ∗∗ p  0.01 ∗∗∗ p  0.001. 1Limited to the 14 tests in Table I. 2The physicians did not estimate a pretest probability or 
mention a presumed diagnosis if they ordered the tests for screening or check-up.
Sc
an
d 
J P
rim
 H
ea
lth
 C
ar
e 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
Ra
db
ou
d 
U
ni
ve
rs
ite
it 
N
ijm
eg
en
 on
 07
/11
/12
Fo
r p
er
so
na
l u
se
 o
nl
y.
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by laboratories the decision limits may also vary, just 
as reference values may vary. Also, decision limits 
vary for specifi c clinical cases. This is complex to 
present and may negatively infl uence the presenta-
tion of laboratory reports. In fact, there is still much 
discussion in clinical laboratory literature, and in 
other areas such as diagnostic imaging, with regard 
to appropriate helpful methods for interpretation of 
test results, as all methods meet specifi c diffi culties 
[ 27 , 28 ]. In their training, physicians often learn to 
interpret results by means of computations involving 
pretest probability, sensitivity, and specifi city, which 
allow the posttest probability to be calculated [ 29,30] . 
This may, however, be diffi cult to apply in the com-
plex environment of routine practice, where the 
results of several tests are usually reported, and where 
several test results may be abnormal [ 31 ]. Greater 
insight into the principles that underlie the interpre-
tation of results in routine care might help to develop 
better methods to support physicians in interpreting 
abnormal results. 
 In conclusion, physicians are likely to be con-
fronted with many marginally abnormal test results, 
even if tests were ordered to reassure or in the case 
of low pretest probability. Given the low pretest 
probability and the statistical defi nition of reference 
values, there is a fair chance that these abnormalities 
have no clinical signifi cance. Therefore, physicians 
should consider carefully whether ordering a test is 
necessary. Furthermore, because the consequences 
of these abnormalities are unclear with respect to 
diagnosis and further management, future research 
should help to better understand physicians’ inter-
pretation of test results and its impact on diagnosis 
and management. 
 Ethics 
 The Medical Ethics Committee of Maastricht 
University approved the study. There was no exter-
nal funding. There are no confl icts of interest. 
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